« Home Research About Contact Us

Neurosearch -USA

Change the future with us

Parkinson's
Disease
Multiple
sclerosis
Alzheimer's
Disease
Post-Ischemic
Stroke


Learn about


Neuro-Diseases
Media
Facts

LEARNING PANEL


POST-ISCHEMIC STROKE


BLOOD LOSS

 

There are two types of ischemic strokes. Thrombotic strokes are caused by a blood clot. (thrombus) in an artery going to the brain. The clot blocks blood flow to part of the brain. Blood clots usually form in arteries damaged by plaque.


Do you or a love one have..

what does it mean?

    The main purpose of this study sponsored by Acorda Therapeutics, Inc is to see if taking dalfampridine-ER tablets twice daily is safe and has an effect on walking abilities in people who have had a stroke. This will be measured by tests of walking and balance, questionnaires, and routine safety tests.

How long is the study?

    The study may involve 12 weeks and longer depending on if you participate on the open-lable phase, The time you will spend in the study will depend on the number of days you are able to complete

How to participate?

    Please take your time to make your decision about taking part. You may discuss your decision with your friends and family. You can also discuss it with your health care team. If you have any questions, you can ask your study doctor for more explanation.

You must be..

  • ≥ 6 months from occurrence of most recent ischemic stroke
  • 18 Years and older
  • evidence of a stable walking deficit due to an ischemic stroke, as judged by the Investigator
  • But cannot be..

  • History of seizures, except simple febrile seizures
  • Suicide attempt within 1 year prior to the Screening Visit, or severe suicidal ideation within 6 months prior to the Screening Visit, or subject is at significant risk of suicidal behavior in the opinion of the Investigator
  • Previous use of AMPYRA, dalfampridine, fampridine or 4-aminopyridine (4-AP)
  • Initiation of a serotonin reuptake inhibitor (SSRI) within 3 months prior to the Screening Visit, or any change in dosing regimen within 3 months prior to the Screening Visit
  • Botulinum toxin use within 2 months prior to the Screening Visit
  •  

    if you are interested or someone you know that might be eligible, fill out our survey form here